Literature DB >> 8992978

The role of B7-1 and LFA-3 in costimulation of CD8+ T cells.

E Parra1, A G Wingren, G Hedlund, T Kalland, M Dohlsten.   

Abstract

This study compares the ability of LFA-3 (CD58) and B7-1 (CD80) ligands to provide costimulatory signals for superantigen (SAg)-stimulated CD8+ and CD4+ T cells. We show that B7-1 and LFA-3 costimulation activate CD8+ T cells to proliferation, cytokine production (IL-2, TNF, and IFN-gamma), and cytotoxicity. A long-lasting proliferative response was observed after combined DR/B7-1/LFA-3 costimulation. Detailed analysis of SEA-activated CD8+ T cells revealed that maximal production of IFN-gamma was seen in LFA-3-costimulated cells, while production of IL-2 was mainly induced after B7-1 costimulation. A fivefold increase in the IFN-gamma production was observed when activated CD8+ T cells were costimulated with Chinese hamster ovary (CHO)-DR/LFA-3 cells compared with the secretion induced by CHO-DR/B7-1. In contrast, SEA-treated CD4+ T cells costimulated with B7-1 or LFA-3 gave rise to a similar production of IFN-gamma, suggesting a preferential function for the CD2/LFA-3 pathway in the regulation of IFN-gamma in CD8+ T cells. Moreover, the generation of CTL was supported similarly by B7-1 and LFA-3 costimulation, but not by CHO-DR cells. We conclude that ligation of the CD28 and CD2 receptors mediate distinct effect on CD8+ and CD4+ T cell effector functions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8992978

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Major histocompatibility complex class II- fetal skin dendritic cells are potent accessory cells of polyclonal T-cell responses.

Authors:  A Elbe-Bürger; A M Mommaas; E E Prieschl; E Fiebiger; T Baumruker; G Stingl
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

2.  Modulation of cytokine release from colonic explants by bacterial antigens in inflammatory bowel disease.

Authors:  S Dionne; S Laberge; C Deslandres; E G Seidman
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

Review 3.  Formation of magnetite by bacteria and its application.

Authors:  Atsushi Arakaki; Hidekazu Nakazawa; Michiko Nemoto; Tetsushi Mori; Tadashi Matsunaga
Journal:  J R Soc Interface       Date:  2008-09-06       Impact factor: 4.118

4.  Superantigen activation of CD4+ and CD8+T cells from HIV-infected subjects: role of costimulatory molecules and antigen-presenting cells (APC)

Authors:  J Vingerhoets; M Dohlsten; G Penne; R Colebunders; D Sansom; E Bosmans; L Kestens; G Vanham
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

5.  Intracellular adhesion molecule-1 modulates beta-chemokines and directly costimulates T cells in vivo.

Authors:  J J Kim; A Tsai; L K Nottingham; L Morrison; D M Cunning; J Oh; D J Lee; K Dang; T Dentchev; A A Chalian; M G Agadjanyan; D B Weiner
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

6.  The detection of sLFA-3 in plasma of patients with hemorrhagic fever with renal syndrome.

Authors:  Ming Xie; Ping Chen; Lin-Jing He; Bao-Tai Qi; Ping Wang; Xiao-Fang Wang; Hui-Xun Ren
Journal:  Clin Exp Med       Date:  2008-09-27       Impact factor: 3.984

7.  Antigen-presenting cells containing multiple costimulatory molecules promote activation and expansion of human antigen-specific memory CD8+ T cells.

Authors:  Sixun Yang; Jeffrey Schlom
Journal:  Cancer Immunol Immunother       Date:  2008-08-09       Impact factor: 6.968

8.  Tumour necrosis factor-alpha (TNF-alpha) transgene-expressing dendritic cells (DCs) undergo augmented cellular maturation and induce more robust T-cell activation and anti-tumour immunity than DCs generated in recombinant TNF-alpha.

Authors:  Weidong Zhang; Zhuang Chen; Fang Li; Huse Kamencic; Bernie Juurlink; John R Gordon; Jim Xiang
Journal:  Immunology       Date:  2003-02       Impact factor: 7.397

Review 9.  CD58 Immunobiology at a Glance.

Authors:  Yalu Zhang; Qiaofei Liu; Sen Yang; Quan Liao
Journal:  Front Immunol       Date:  2021-06-08       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.